LCN2 and psoriasis: It is currently believed that IL17A is the core driving factor of the pathogenesis of psoriasis, and LCN2 plays an indispensable role in this disease by acting as an antibacterial peptide and as a trigger for neutrophil activation in psoriasis (Shao et al., 2016; Frieder et al., 2018).